Biomind Labs Inc

Research Biomind Labs Inc (BMND) on Bullrun: market cap CAD 12.80M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerBMND
• ExchangeNEO
• CountryCanada
• SectorHealthcare
• IndustryBiotechnology
• CurrencyCAD
• Market capCAD 12.80M
• Financial periodQ4 2025
• Net income-CAD 564.35K
• Free cash flow-CAD 48.96K

Valuation Snapshot

latest market cap is CAD 12.80M.

About Biomind Labs Inc

Biomind Labs Inc., a biotech research and development company, focuses on developing novel pharmaceutical drugs and nanotech delivery systems for various psychiatric and neurological conditions. The company is developing BMND01, which is in Phase II clinical trials for use in the treatment of depression; BMND08, a 5-Metoxi-N,N-dimethyltryptamine sublingual formulation that is in Phase II clinical trials for treatment of depression and anxiety in patients with Alzheimer's disease;

Frequently asked questions

What is Biomind Labs Inc's market cap?

Biomind Labs Inc's market capitalization is CAD 12.80M.

What does Biomind Labs Inc do?

Biomind Labs Inc., a biotech research and development company, focuses on developing novel pharmaceutical drugs and nanotech delivery systems for various psychiatric and neurological conditions.